![3-[(3S,4S)-4-methyl-3-[methyl({7H-pyrrolo[2,3-d]pyrimidin-4-yl})amino]piperidin-1-yl]-3-oxopropanenitrile structure, CAS 2174011-55-1](/structures/210000/200044_1_2174011_55_1.png)
| Chemical & Physical Properties | |
|---|---|
| CAS Number | 2174011-55-1 |
| Catalog No. | 2A-1198159 |
| Chinese Name | 托法替尼杂质C枸橼酸 |
| Synonyms | Tofacitinib Impurity C Citrate; Tofacitinib Impurity TFB-C |
| Molecular Formula | C16H20O1N6 |
| Molecular Weight | 312.37 |
| Purity | 98.00 |
| MDL Number | MFCD23160057 |
| SMILES | CC1CCN(C(=O)CC#N)CC1N(C)c1ncnc2[nH]ccc12.O=C(O)CC(O)(CC(=O)O)C(=O)O |
| InChI Key | SYIKUFDOYJFGBQ-STEACBGWSA-N |
| MSDS | msds/200044_1_2174011_55_1.pdf |
| Related Products in Pharmaceutical Intermediates | ||
|---|---|---|
| 5-(((tert-butoxycarbonyl)amino)methyl)-2-chlorobenzoic acid | 165950-04-9 | 2A-2198109 |
| tert-butyl 3-((tert-butoxycarbonyl)oxy)azetidine-1-carboxylate | 1785763-73-6 | 2A-2198121 |
| (S)-2-(3-bromophenyl)propanoic acid | 1146411-14-4 | 2A-2198125 |
| (R)-MG132 | 1211877-36-9 | 2A-2198136 |
| 2-[4-[(3R,5R,8R,9S,10S,12S,13R,14S,17R)-3,12-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoylamino]ethanesulfonic acid | 516-50-7 | 2A-1198152 |
| 1-(tert-butoxycarbonyl)-3,3-difluoropiperidine-4-carboxylic acid | 1303972-81-7 | 2A-2198199 |
| Sacubitril-(2R,4R)-Isomer | 2259708-00-2 | 2A-1198209 |
| Trihexyl(tetradecyl)phosphoniumbis(trifluoromethanesulfonyl)amide | 460092-03-9 | 2A-2198230 |
| 1-(tert-butoxycarbonyl)-4,4-difluoropiperidine-3-carboxylic acid | 1303974-65-3 | 2A-2198243 |
| 2-(1-(tert-butoxycarbonyl)-4,4-difluoropiperidin-3-yl)acetic acid | 1334417-29-6 | 2A-2198266 |
| Browse all Pharmaceutical Intermediates products » | ||
Phone:
630-322-8886
630-322-8887
Email:
Office Locations:
Chicago, IL, USA
San Francisco, CA, USA